ELAN - CIK 0001739104
Elanco Animal Health Inc (ELAN) reported net income of -$232.00M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$232.00M | -168.6% |
| FY 2024 | $338.00M | +127.5% |
| FY 2023 | -$1.23B | -1478.2% |
| FY 2022 | -$78.00M | +83.9% |
| FY 2021 | -$483.00M | +15.9% |
| FY 2020 | -$574.00M | -944.1% |
| FY 2019 | $68.00M | -21.4% |
| FY 2018 | $86.50M | +127.8% |
| FY 2017 |
Elanco Animal Health Inc (ELAN) reported net income of -$232.00M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2016 and fiscal 2025, Elanco Animal Health Inc's net income declined from -$47.90M to -$232.00M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$310.70M |
| -548.6% |
| FY 2016 | -$47.90M | - |